Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panzytrat self-dosage vs fixed-dose in exocrine pancreatic insufficiency
2010-020303-69Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of pancrelipase in exocrine pancreatic insufficiency (EPI), chronic pancreatitis (CP) and steatorrhea (2 arms), sponsored by Erasmus MC. Started Sep 2011; status: active.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)chronic pancreatitis (CP)steatorrhea
Beyond the preview
Go deeper on 2010-020303-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020303-69.